Monodes (N-carboxymethyl) valine Daclatasvir (TFA)

Monodes (N-carboxymethyl) valine Daclatasvir TFA (Daclatasvir Impurity A TFA) is the TFA salt form of Monodes (N-carboxymethyl) valine Daclatasvir (HY-133246) . Monodes (N-carboxymethyl) valine Daclatasvir TFA is the main degradation product of Daclatasvir (HY-10466) . Daclatasvir is a potent HCV NS5A protein inhibitor[1].

Product Specifications

Product Name Alternative

Daclatasvir Impurity A (TFA)

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

HCV

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/monodes-n-carboxymethyl-valine-daclatasvir-tfa.html

Purity

99.89

Smiles

COC(N[C@@H](C(C)C)C(N(CCC1)[C@@H]1C2=NC(C3=CC=C(C4=CC=C(C5=CNC([C@H]6NCCC6)=N5)C=C4)C=C3)=CN2)=O)=O.OC(C(F)(F)F)=O

Molecular Formula

C35H40F3N7O5

Molecular Weight

695.73

Precautions

H302, H315, H319, H335

References & Citations

[1]Naz A , et al. Simultaneous analysis of daclatasvir with its three organic impurities: Application in stability studies, pharmaceutical and serum samples[J]. Microchemical Journal, 2019.